References
1. Schild M, Meurer M. [Vitiligo: Clinical presentation and pathogenesis]. Hautarzt. 2016 Feb;67(2):173-86; quiz 187-9.
2. Karadag R, Esmer O, Karadag AS, Bilgili SG, Cakici O, Demircan YT, et al. Evaluation of ocular findings in patients with vitiligo. Int J Dermatol. 2016 Mar;55(3):351-5.
3. Biswas G, Barbhuiya JN, Biswas MC, Islam MN, Dutta S. Clinical pattern of ocular manifestations in vitiligo. J Indian Med Assoc. 2003 Aug;101(8):478-80.
4. Cook CS, Ozanis V, Jakobiec FA. Prenatal development of the eye and its adnexa. In: Tasman W (ed.) Duane’s Ophthalmology. Lippincot-Raven Publishers, Inc: Philadelphia, 1991, pp 1–93.
5. Ornek N, Onaran Z, Koçak M, Ornek K. Retinal nerve fiber layer thickness in vitiligo patients. J Res Med Sci. 2013 May;18(5):405-7.
6. Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A. Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol. 2006 Aug;20(7):829-33.
7. Kurt A, Kurt EE, Kilic R, Oktem C, Tuncay F, Erdem HR. Is choroidal thickness related with disease activity and joint damage in patient with rheumatoid arthritis. Bratisl Lek Listy. 2017; 118 (1): 23-7.
8. Rogosić V, Bojić L, Puizina-Ivić N, Vanjaka-Rogosić L, Titlić M, Kovacević D, et al. Vitiligo and glaucoma - an association or a coincidence? A pilot study. Acta Dermatovenerol Croat. 2010;18(1):21-6. Erratum in: Acta Dermatovenerol Croat. 2010 Jul;18(2):119.
9. Shoeibi N, Taheri AR, Nikandish M, Omidtabrizi A, Khosravi N. Electrophysiologic evaluation of retinal function in patients with psoriasis and vitiligo. Doc Ophthalmol. 2014 Apr;128(2):131-6.
10. Perossini M, Turio E, Perossini T, Cei G, Barachini P. Vitiligo: ocular and electrophysiological findings. G Ital Dermatol Venereol. 2010 Apr;145(2):141-9.
11. Albert DM, Nordlund JJ, Lerner AB. Ocular abnormalities occurring with vitiligo. Ophthalmology. 1979 Jun;86(6):1145-60.
12. Kim M, Kwon JW, Park YH. Atypical Pattern of Choroidal Hypopigmentation with Cutaneous Vitiligo. Korean J Ophthalmol. 2019 Feb;33(1):99-100.
13. Ciardella AP, Horsley MB, Brown DM. Hypopigmentary fundus changes seen with cutaneous vitiligo. Arch Ophthalmol. 2007 Apr;125(4):576. Erratum in: Arch Ophthalmol. 2007 Jun;125(6):849.
14. Aksoy Y, Çolakoglu K, Kar T, Sevinc MK, Eyi YE. Choroidal thickness is affected by more factors than estimated. Invest Ophthalmol Vis Sci. 2014 Mar 4;55(3):1311.
15. Thomas MG, Kumar A, Mohammad S, Proudlock FA, Engle EC, Andrews C, et al. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity? Ophthalmology. 2011 Aug;118(8):1653-60.
16. Seo JH, Yu YS, Kim JH, Choung HK, Heo JW, Kim SJ. Correlation of visual acuity with foveal hypoplasia grading by optical coherence tomography in albinism. Ophthalmology. 2007 Aug;114(8):1547-51.
17. Karabas L, Esen F, Celiker H, Elcioglu N, Cerman E, Eraslan M, et al. Decreased subfoveal choroidal thickness and failure of emmetropisation in patients with oculocutaneous albinism. Br J Ophthalmol. 2014;98:1087–90.
18. Demirkan S, Onaran Z, Samav G, Özkal F, Yumuşak E, Gündüz Ö, et al. Decreased choroidal thickness in vitiligo patients. BMC Ophthalmol. 2018 May 29;18(1):126.
19. Street D, Sivaguru A, Sreekantam S, Mollan SP. Vogt-Koyanagi-Harada disease. Pract Neurol. 2019 Aug;19(4):364-367.
20. Perente I, Utine CA, Cakir H, Kaya V, Tutkun IT, Yilmaz OF. Management of ocular complications of Vogt-Koyanagi-Harada syndrome. Int Ophthalmol. 2009 Feb;29(1):33-7. Epub 2007 Oct 19.
21. Zangwill LM, Bowd C. Retinal nerve fiber layer analysis in the diagnosis of glaucoma. Curr Opin Ophthalmol. 2006 Apr;17(2):120-31.
22. Dertlioglu SB, Oguz H, Cicek D, Yücel H. Prevalence of glaucoma in patients with vitiligo. Cutis 2016;97: 21–25.
23. Duplancić D, Rogosić V, Puizina-Ivić N, Rogosić LV, Luksić B, Kovacić V, et al. [Prognostic value of ophthalmic artery color Doppler sonography for progression to glaucoma in vitiligo patients]. Acta Med Croatica. 2013 Mar;67(1):47-52.
24. Daniel BS, Orchard D. Ocular side-effects of topical corticosteroids: what a dermatologist needs to know. Australas J Dermatol. 2015 Aug;56(3):164-9.
25. David DS, Berkowitz JS. Ocular effects of topical and systemic corticosteroids. Lancet. 1969 Jul 19;2(7612):149-51.
26. Khurrum H, Alhamdi KM, Osman E. Screening of glaucoma or cataract prevalence in Vitiligo patients and its relationship with periorbital steroid use. J Cutan Med Surg. 2016 Mar-Apr; 20 (2): 146-9.
27. Kurysheva NI, Maslova EV, Zolnikova IV, Fomin AV, Lagutin MB. A comparative study of structural, functional and circulatory parameters in glaucoma diagnostics. PLoS One. 2018 Aug 23;13(8):e0201599.
28. Tang M, Pawlyk BS, Kosaras B, Berson EL, Sidman RL. ERG abnormalities in relation to histopathologic findings in vitiligo mutant mice. Exp Eye Res. 1997 Aug;65(2):215-22.
29. Aydin R, Ozsutcu M, Erdur SK, Dikkaya F, Balevi A, Ozbek M, et al. The assessment of macular electrophysiology and macular morphology in patients with vitiligo. Int Ophthalmol. 2018 Feb;38(1):233-239.